10:20 AM EDT, 05/08/2025 (MT Newswires) -- Novavax ( NVAX ) shares were up over 16% in recent Thursday trading after the company reported it swung to Q1 net income of $2.93 per diluted share from a net loss of $1.05 a year earlier.

Three analysts polled by FactSet expected a loss of $0.42.

Revenue for the quarter ended March 31 was $666.7 million, up from $93.9 million a year earlier.

Two analysts surveyed by FactSet expected $91.7 million.

The drugmaker said it expects 2025 adjusted total revenue of between $975 million and $1.03 billion.

Price: 6.93, Change: +0.98, Percent Change: +16.47